Abstract
Much has been written about the growing prevalence of CKD, especially CKD caused by diabetic nephropathy. Despite increased awareness of CKD as a worldwide medical problem, there remain few pharmacological therapies available to prevent or slow the progression of CKD to ESRD, much less therapies
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Clinical Journal of the American Society of Nephrology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.